|
We're proud of the talented people in our company. What we're building is incredibly difficult and would not be possible without working with the best team of scientists and operators. Nanoly is a venture-backed company.
We're always looking for the best and brightest people to join us. Visit our career page for more info. |
|
|
Balaji Sridhar, PhD, CEO
PhD, Chemical Engineering, University of Colorado BS Chemical-Biological Engineering, MIT Dr. Sridhar comes from 10 years of experience in biotechnology research including microscopy, polymer fabrication, and organic chemistry verification. Dr. Sridhar has worked as a researcher at MIT’s Langer Lab and for Chevron Corporation. He completed his Ph.D. in renowned tissue engineer Kristi Anseth's Lab. Nanxi Liu, CFO BS Business Administration and BA Political Economy, University of California, Berkeley Named Forbes 30 Under 30, Nanxi also co-founded and serves as CEO of Enplug, a leading digital signage software company. Nanxi previously worked in investment banking at Goldman Sachs and serves as an advisory board member of Covington Capital Management ($2 billion AUM). David Busha, PhD, Head of Commercial Development PhD Molecular, Cellular & Developmental Biology, MA Psychology/Neuroscience, University of Colorado, Boulder BA Neuroscience, Macalester College Dr. Busha has 9 years of biotech experience including as a core member at Five Prime Therapeutics where he developed several immuno oncology protein therapeutics. He has extensive experience designing novel protein molecules, recombinant fusion proteins, and bispecific antibodies. |
Mark Tibbitt, PhD, CTO
Postdoctoral Fellow, MIT PhD Chemical and Biological Engineering, University of Colorado, Boulder BA Integrated Science and Mathematics, Northwestern University Dr. Tibbitt has 9 years of research experience, with emphasis on hydrogels and microparticles. Dr. Tibbitt has conducted research for Hollings Marine Laboratory and NASA. His research was awarded at the World Biomaterials Congress in 2012. John Janczy, PhD, Head of R&D Postdoctoral Fellow, University of Colorado Anschutz Medical Campus PhD Immunology, University of Iowa BS Biology, Colorado Mesa University Dr. Janczy has over 6 years of experience in inflammation and immunology research. His work has focused primarily on pathogen recognition and the modulation of innate and adaptive immune responses. Two of his most recent publications are: “Immune complexes inhibit IL-1 secretion and inflammasome activation” (Journal of Immunology) and “Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation” (Immunity). |
